Illumina Partners Advance Cancer Research with Multiomics Technologies
Studies demonstrate spatial transcriptomics, 5-base sequencing, and proteomics applications in oncology diagnostics and therapeutic development.
Read More
Search Results for: liver disease
HistoIndex Expands AI Liver Disease Diagnostic Access in Texas and California
HistoIndex has partnered with Houston Research Institute and Knowledge Research Center to expand access to AI-driven digital pathology for liver disease diagnostics in Texas and California.
Read More
Blue Shield of California Expands Coverage for Metastatic CNS Cancer Assay
Blue Shield of California will cover Plus Therapeutics’ CNSide CSF assay for metastatic CNS cancers starting April 2026, expanding total covered lives to 81 million, according to the company.
Read More
FDA Grants Breakthrough Status to Blood Test to Distinguish Schizophrenia and Bipolar Disorder
The mRNA-based test aims to provide objective data to help clinicians distinguish between psychiatric conditions that often share symptoms.
Read More
New Clinical Data Supports Blood-Based Monitoring for Cancer Treatment Response
Personalis presented data at AACR showing its NeXT Personal assay enabled ultrasensitive ctDNA monitoring for colorectal and lung cancer patients, demonstrating 100% sensitivity at baseline and 100% specificity for relapse post-surgery.
Read More